These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10712086)

  • 21. Using a clinical pathway and education to reduce inappropriate prescribing of enoxaparin in patients with acute coronary syndromes: a controlled study.
    Buckmaster ND; Heazlewood V; Scott IA; Jones M; Haerer W; Hillier K
    Intern Med J; 2006 Jan; 36(1):12-8. PubMed ID: 16409308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of unstable coronary disease].
    Préda I
    Orv Hetil; 2002 Apr; 143(15):757-65. PubMed ID: 11979994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy.
    Goodman SG; Bozovich GE; Tan M; Dos Santos A; Gurfinkel EP; Cohen M; Langer A;
    Am Heart J; 2006 Apr; 151(4):791-7. PubMed ID: 16569535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose capping enoxaparin is unjustified and denies patients with acute coronary syndromes a potentially effective treatment.
    Spinler SA; Dobesh P
    Chest; 2005 Jun; 127(6):2288-9; author reply 2289-90. PubMed ID: 15947357
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hirudin is superior to heparin in reducing cardiovascular mortality, infarct and refractory angina in patients with unstable angina or myocardial infarct without elevation of the ST tract].
    Franzosi MG
    Ital Heart J Suppl; 2000 Sep; 1(9):1210-2. PubMed ID: 11140295
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin.
    Montalescot G; Collet JP; Tanguy ML; Ankri A; Payot L; Dumaine R; Choussat R; Beygui F; Gallois V; Thomas D
    Circulation; 2004 Jul; 110(4):392-8. PubMed ID: 15249498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of enoxaparin in a patient with unstable angina.
    Wang JC; Goldhaber SZ; Popma JJ
    J Invasive Cardiol; 2000; 12 Suppl C():18C-20C. PubMed ID: 10762864
    [No Abstract]   [Full Text] [Related]  

  • 28. Low molecular weight heparins (enoxaparin) in the management of unstable angina: the TIMI studies. Thrombolysis in Myocardial Infarction.
    Gurfinkel E; Scirica BM
    Heart; 1999 Sep; 82 Suppl 1(Suppl 1):I15-7. PubMed ID: 10469673
    [No Abstract]   [Full Text] [Related]  

  • 29. Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial.
    Mahaffey KW; Ferguson JJ
    Am Heart J; 2005 Apr; 149(4 Suppl):S81-90. PubMed ID: 16124952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes: factoring in new trials and meta-analysis data.
    Topol EJ
    Am Heart J; 2005 Apr; 149(4 Suppl):S100-6. PubMed ID: 16124950
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical benefit of enoxaparin in patients with high-risk acute coronary syndromes without ST elevations in clinical practice.
    Zeymer U; Gitt A; Jünger C; Koeth O; Zahn R; Wienbergen H; Gottwik M; Senges J;
    Am J Cardiol; 2006 Jul; 98(1):19-22. PubMed ID: 16784913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Editor's Roundtable: arterial thrombosis and acute coronary syndromes.
    Friedewald VE; Bates ER; Granger CB; Yusuf S; Roberts WC
    Am J Cardiol; 2007 Sep; 100(6):974-80. PubMed ID: 17826381
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction.
    Baird SH; Menown IB; Mcbride SJ; Trouton TG; Wilson C
    Eur Heart J; 2002 Apr; 23(8):627-32. PubMed ID: 11969277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the preoperative administration of enoxaparin 40 mg necessary to optimally prevent the occurrence of venous thromboembolism after hip surgery? A subanalysis of two pooled randomized trials.
    Lassen MR
    J Thromb Haemost; 2009 May; 7(5):889-91. PubMed ID: 19245416
    [No Abstract]   [Full Text] [Related]  

  • 35. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
    Mehta SR; Granger CB; Eikelboom JW; Bassand JP; Wallentin L; Faxon DP; Peters RJ; Budaj A; Afzal R; Chrolavicius S; Fox KA; Yusuf S
    J Am Coll Cardiol; 2007 Oct; 50(18):1742-51. PubMed ID: 17964037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of venous thromboembolism after orthopedic surgery: the EXPRESS study.
    Cimminiello C; Planès A; Samama MM
    J Thromb Haemost; 2004 Nov; 2(11):2036-40. PubMed ID: 15550036
    [No Abstract]   [Full Text] [Related]  

  • 38. Can enoxaparin safely replace unfractionated heparin during coronary intervention in acute coronary syndromes?
    Wolak A; Ayzenberg Y; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2004 Aug; 96(2):151-5. PubMed ID: 15262028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
    Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimising outcomes: socioeconomic perspective.
    Mark DB
    Heart; 1999 Sep; 82 Suppl 1(Suppl 1):I18-20. PubMed ID: 10469674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.